ATEA PHARMACEUTICALS INC's ticker is AVIR and the CUSIP is 04683R106. A total of 105 filers reported holding ATEA PHARMACEUTICALS INC in Q2 2024. The put-call ratio across all filers is 4.43 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $1,967,764 | +27.2% | 594,360 | +55.2% | 0.00% | – |
| Q1 2024 | $1,547,044 | +449.2% | 382,932 | +314.6% | 0.00% | – |
| Q4 2023 | $281,670 | +1.7% | 92,351 | 0.0% | 0.00% | – |
| Q3 2023 | $277,053 | -19.8% | 92,351 | 0.0% | 0.00% | – |
| Q2 2023 | $345,393 | +67.3% | 92,351 | +49.8% | 0.00% | – |
| Q1 2023 | $206,491 | -9.0% | 61,639 | +1573.6% | 0.00% | – |
| Q1 2021 | $227,000 | – | 3,683 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 2,485,638 | $14,143,000 | 1.69% |
| CM Management, LLC | 250,000 | $1,423,000 | 1.59% |
| Ally Bridge Group (NY) LLC | 360,000 | $2,048,000 | 1.35% |
| EcoR1 Capital, LLC | 6,184,861 | $35,192,000 | 1.04% |
| Cormorant Asset Management, LP | 1,547,181 | $8,803,000 | 0.62% |
| K2 PRINCIPAL FUND, L.P. | 605,419 | $3,445,000 | 0.40% |
| FEDERATED HERMES, INC. | 3,626,818 | $20,637,000 | 0.06% |
| PDT Partners, LLC | 68,754 | $391,000 | 0.06% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 355,612 | $2,023,000 | 0.05% |
| Virtus ETF Advisers LLC | 15,660 | $89,000 | 0.04% |